These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7368169)

  • 21. Anticoagulating and non-enzymatic fibrinolytic activities of heparin-antithrombin III and antithrombin III-heparin-thrombin complexes in vitro and in vivo.
    Kudrjashov BA; Pastorova VE; Lyapina LA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):731-42. PubMed ID: 6198257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coagulation protein function VI: augmentation of anticoagulant function by acetaldehyde-treated heparin.
    Brecher AS; Hellman K; Basista MH
    Dig Dis Sci; 1999 Jul; 44(7):1349-55. PubMed ID: 10489917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A retrospective study of the pharmacokinetics of heparin.
    Estes JW; Pelikan EW; Krüger-Thiemer E
    Clin Pharmacol Ther; 1969; 10(3):329-37. PubMed ID: 5795800
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparison of the strength of binding of antithrombin III, protamine and poly(L-lysine) to heparin samples of different anticoagulant activities.
    Jones GR; Hashim R; Power DM
    Biochim Biophys Acta; 1986 Aug; 883(1):69-76. PubMed ID: 3730427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutralization of heparin with protamine (salmine).
    PARKIN TW; EVALE WF
    Proc Annu Meet Cent Soc Clin Res U S; 1947; 20():5. PubMed ID: 20272769
    [No Abstract]   [Full Text] [Related]  

  • 26. Interrelationship of protamine and platelet factor 4 in the neutralization of heparin.
    Shanberge JN; Quattrociocchi-Longe TM; Martens MH
    Thromb Res; 1987 Apr; 46(1):89-100. PubMed ID: 3590116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Protamine dosage for heparin neutralization in open-heart surgery (author's transl)].
    Shiao K
    Fukuoka Igaku Zasshi; 1974 Nov; 65(11):878-88. PubMed ID: 4477114
    [No Abstract]   [Full Text] [Related]  

  • 28. Interaction studies with metolazone, heparin and protamine sulfate.
    Yelnosky J; Borrelli A; Kaiser F; Belair E
    Arch Int Pharmacodyn Ther; 1973 Jul; 204(1):5-11. PubMed ID: 4746632
    [No Abstract]   [Full Text] [Related]  

  • 29. Body response to a second dose of heparin after heparin neutralization by protamine.
    Belko JS; Lerman SF
    J Cardiovasc Surg (Torino); 1966; 7(3):219-21. PubMed ID: 5938808
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of protamine (salmine) on the white blood count.
    VARTIAINEN I; VARTIAINEN O
    Ann Med Exp Biol Fenn; 1951; 29(1):52-5. PubMed ID: 14915194
    [No Abstract]   [Full Text] [Related]  

  • 31. Anticoagulant activity of a bacterial glycopeptide.
    Akoum A; Josefonvicz J; Sigot M
    Thromb Res; 1990 Oct; 60(1):9-18. PubMed ID: 2126150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Action of protamine sulfate of the heparin-like substance of follicular fluid].
    PALLA V
    Minerva Ginecol; 1952 Apr; 4(5):164-74. PubMed ID: 14956742
    [No Abstract]   [Full Text] [Related]  

  • 33. Neutralization of the anticoagulant effects of heparin with protamine (salmine).
    PARKIN TW; KVALE WF
    Am Heart J; 1949 Mar; 37(3):333-42. PubMed ID: 18110419
    [No Abstract]   [Full Text] [Related]  

  • 34. [In vitro and in vivo neutralisation of a low molecular weight heparin fraction CY 216 by protamine].
    Doutremepuich C; Bonini F; Masse A; Bousquet F; Bayrou B; Toulemonde F
    Ann Pharm Fr; 1986; 44(1):65-72. PubMed ID: 3777780
    [No Abstract]   [Full Text] [Related]  

  • 35. Results of low-dose heparin prophylaxis of venous thrombosis considering plasma heparin and anti-thrombin III concentration.
    Tilsner V; Müller U; Reuter H; Raedler A
    Thromb Res; 1980 Feb 1-15; 17(3-4):519-25. PubMed ID: 7368173
    [No Abstract]   [Full Text] [Related]  

  • 36. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.
    Yamamoto T; Wolf HG; Sinzobahamvya N; Asfour B; Hraska V; Schindler E
    Thorac Cardiovasc Surg; 2015 Aug; 63(5):397-403. PubMed ID: 26121380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of protamine (salmine) on the body weight.
    VARTIAINEN I; VARTIAINEN O
    Ann Med Exp Biol Fenn; 1951; 29(1):41-7. PubMed ID: 14915192
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experimental study of the heparin antagonist protamine chloride].
    Efimov VS
    Farmakol Toksikol; 1968; 31(5):601-4. PubMed ID: 5707736
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of protamine (salmine) in the weight of the organs of the body.
    VARTIAINEN I; VARTIAINEN O
    Ann Med Exp Biol Fenn; 1951; 29(1):48-51. PubMed ID: 14915193
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on the anticoagulant action of heparin, protamine, and Polybrene in the activation of factor IX.
    Shanberge JN; Fukui H
    J Lab Clin Med; 1967 Jun; 69(6):927-37. PubMed ID: 6025496
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.